Diagnosis

Amyloid plaques forming between neurons, 3d illustration. Beta-amyloid protein disrupting nerve cells function in a brain with Alzheimer's disease

Vascular Cognitive Impairment and Dementia: How Prevention Holds the Key

As the second most common cause of dementia after Alzheimer’s disease (AD) in North America and Europe, vascular cognitive impairment and dementia (VCID) accounts for…
CURATED BY: Debbie A. Gunter,
RN, FNP-BC, ACHPN

Patient Management Guidelines

Articles

Human brain disintegrating or breaking apart 3D rendering illustration. Memory impairments, neurological diseases like Parkinson's or Alzheimer's, amnesia, psychological disorders concepts.

Understanding Vascular Cognitive Impairment and Dementia: Key Pathological Mechanisms

Vascular cognitive impairment and dementia (VCID) is the second most common cause of dementia after Alzheimer’s disease (AD), accounting for...
CURATED BY:
Debbie A. Gunter,
RN, FNP-BC, ACHPN

Vascular Dementia: A Complex Challenge in Aging Populations

Vascular dementia (VaD), the second most prevalent dementia type after Alzheimer’s disease (AD), predominantly affects individuals over 65 years old...
CURATED BY:
Eric Carlon,
APRN, PMHNP-BC

Navigating Neurodegenerative Diseases: Biomarkers Key to Early Detection

Neurodegenerative diseases like Alzheimer’s (AD), amyotrophic lateral sclerosis (ALS), and Parkinson’s (PD) are rising global health challenges, impairing cognition, motor...
CURATED BY:
Eric Carlon,
APRN, PMHNP-BC

Saliva Shows Promise as a Non-Invasive Diagnostic Tool for Alzheimer’s Disease

Alzheimer’s disease (AD) is a prevalent neurodegenerative condition affecting millions worldwide, with projections indicating that the number of dementia cases...
CURATED BY:
Stacey Panasci,
MS, PA-C, MSCS

Study Identifies APOE4 Homozygosity as a Distinct Genetic Form of Alzheimer’s Disease

Researchers of a study have revealed that individuals with two copies of the APOE4 gene variant are almost certain to...
CURATED BY:
Debbie A. Gunter,
RN, FNP-BC, ACHPN

Study Emphasizes AI and Neuroimaging Progress in Early Alzheimer’s Disease Detection

This review explores the use of neuroimaging and artificial intelligence (AI), including machine learning (ML), for early Alzheimer's disease (AD)...
CURATED BY:
Eric Carlon,
APRN, PMHNP-BC
Share